Showing results (921-930 of 1,142) with videos related to

Sort By:
Pageof 115
Diabetologia|June 16, 2020
Cardiometabolic risk factors as determinants of peripheral nerve function: the Maastricht StudyJeroen H P M van der Velde, Annemarie Koster, Elsa S Strotmeyer, et al.
BMJ Open Diabetes Research & Care|February 18, 2021
Spousal concordance in pathophysiological markers and risk factors for type 2 diabetes: a cross-sectional analysis of The Maastricht StudyOmar Silverman-Retana, Stephanie Brinkhues, Adam Hulman, et al.
The Journal of Clinical Endocrinology and Metabolism|December 3, 2014
Associations of advanced glycation end-products with cognitive functions in individuals with and without type 2 diabetes: the maastricht studyP J J Spauwen, M G A van Eupen, S Köhler, et al.
Diabetes Care|August 27, 2017
The Role of Hyperglycemia, Insulin Resistance, and Blood Pressure in Diabetes-Associated Differences in Cognitive Performance-The Maastricht StudyStefan L C Geijselaers, Simone J S Sep, Danny Claessens, et al.
Neuropsychology|August 29, 2024
The association of sociodemographic factors with total and item-level semantic fluency metricsMagdalena Beran, Emma L Twait, Annelot P Smit, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 15, 2016
Albuminuria is associated with a higher prevalence of depression in a population-based cohort study: the Maastricht StudyRemy J H Martens, Jeroen P Kooman, Coen D A Stehouwer, et al.
Journal of Hypertension|November 13, 2020
Exercise SBP response and incident depressive symptoms: The Maastricht StudyTan Lai Zhou, Abraham A Kroon, Ronald M A Henry, et al.
Heart (British Cardiac Society)|January 23, 2016
Direct comparison of clinical decision limits for cardiac troponin T and IDorien M Kimenai, Ronald M A Henry, Carla J H van der Kallen, et al.
BMC Public Health|December 20, 2017
Socially isolated individuals are more prone to have newly diagnosed and prevalent type 2 diabetes mellitus - the Maastricht studyStephanie Brinkhues, Nicole H T M Dukers-Muijrers, Christian J P A Hoebe, et al.
JAMA Oncology|November 17, 2022
Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled TrialTimothy A Yap, Aditya Bardia, Michael Dvorkin, et al.
Pageof 115